Adage Capital Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.7M | Buy |
447,000
+399,000
| +831% | +$41.7M | 0.08% | 251 |
|
|
2025
Q1 | $5.6M | Sell |
48,000
-12,000
| -20% | -$1.4M | 0.01% | 681 |
|
|
2024
Q4 | $5.08M | Sell |
60,000
-465,000
| -89% | -$39.3M | 0.01% | 716 |
|
|
2024
Q3 | $47.2M | Sell |
525,000
-205,000
| -28% | -$18.4M | 0.08% | 243 |
|
|
2024
Q2 | $58.8M | Buy |
730,000
+215,000
| +42% | +$17.3M | 0.11% | 193 |
|
|
2024
Q1 | $41.1M | Buy |
515,000
+150,000
| +41% | +$12M | 0.08% | 273 |
|
|
2023
Q4 | $29.1M | Buy |
365,000
+40,000
| +12% | +$3.18M | 0.06% | 329 |
|
|
2023
Q3 | $22.7M | Sell |
325,000
-119,417
| -27% | -$8.35M | 0.05% | 360 |
|
|
2023
Q2 | $31.9M | Sell |
444,417
-605,583
| -58% | -$43.5M | 0.07% | 282 |
|
|
2023
Q1 | $64.8M | Sell |
1,050,000
-15,000
| -1% | -$925K | 0.15% | 169 |
|
|
2022
Q4 | $82.1M | Buy |
1,065,000
+915,000
| +610% | +$70.6M | 0.2% | 128 |
|
|
2022
Q3 | $6.69M | Sell |
150,000
-633,662
| -81% | -$28.3M | 0.02% | 738 |
|
|
2022
Q2 | $30M | Buy |
783,662
+133,662
| +21% | +$5.12M | 0.07% | 300 |
|
|
2022
Q1 | $26.9M | Buy |
+650,000
| New | +$26.9M | 0.05% | 373 |
|
|
2020
Q4 | – | Sell |
-200,000
| Closed | -$14.3M | – | 809 |
|
|
2020
Q3 | $14.3M | Hold |
200,000
| – | – | 0.04% | 457 |
|
|
2020
Q2 | $16.5M | Buy |
200,000
+115,000
| +135% | +$9.46M | 0.04% | 430 |
|
|
2020
Q1 | $5M | Buy |
+85,000
| New | +$5M | 0.01% | 571 |
|